Real-time enrollment status for this metabolic dysfunction-associated steatotic liver disease clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:14 PM UTC
| NCT Number | NCT07192159 |
| Recruiting Status | Recruiting |
| Condition | Metabolic Dysfunction-Associated Steatotic Liver Disease |
| Phase | Clinical Trial |
| Target Enrollment | 62 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Seoul National University Hospital |
| Last Updated on CT.gov | September 25, 2025 (Sep 25, 2025) |
As of July 13, 2026: Clinical trial NCT07192159 is currently recruiting participants. This clinical trial study for metabolic dysfunction-associated steatotic liver disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Seoul National University Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07192159 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07192159 was last updated Sep 25, 2025 (September 25, 2025). HelloStudys verifies this status automatically.